Biotech Values

[DewDiligence]

IMS report on global pharma sales states the obvious:

http://www.nytimes.com/2012/07/13/business/global/drug-makers-growth-seen-in-emerging-markets.html

In China, the report estimates, drug spending will amount to about $121 a person in 2016, which is far less than the $892 a person expected to be spent in the United States. But given that two-thirds of the world’s population lives in those emerging markets, even modest increases can make a big difference.

Spending is expected to double in these markets in the next five years, growing by a projected range of $150 billion to $165 billion, the report found. By 2016, 30 percent of global spending on medicines will be in the emerging markets, compared with 20 percent in 2011.